Small bowel adenocarcinoma in Crohn's disease

Authors

  • Richard C. Feldstein MD, MS,

    1. Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, North Shore University Hospital-Long Island Jewish Medical Center, New York University School of Medicine, Manhasset, New York
    Search for more papers by this author
  • Shivani Sood MD, MPH,

    1. Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, North Shore University Hospital-Long Island Jewish Medical Center, New York University School of Medicine, Manhasset, New York
    Search for more papers by this author
  • Seymour Katz MD, FACP, MACG

    Corresponding author
    1. Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, North Shore University Hospital-Long Island Jewish Medical Center, New York University School of Medicine, Manhasset, New York
    • 1000 Northern Blvd,. Great Neck, NY 11021
    Search for more papers by this author

Abstract

Small bowel neoplastic disease is a rare but dreaded occurrence in Crohn's disease (CD) and the diagnosis is often disguised by nonspecific and varied presenting symptoms mimicking active or obstructive CD. As such, the diagnosis is all too often delayed, typically detected at a late stage, and with a poor prognosis. CD has become a well-recognized risk factor for the development of small bowel adenocarcinoma. The data, however, are limited and based on case reports, retrospective studies, and review of the literature.

(Inflamm Bowel Dis 2008)

Ancillary